Advertisement

CNS Drugs

, Volume 20, Issue 4, pp 327–329 | Cite as

Reports of Acute Angle Closure Glaucoma-Related Adverse Events with SSRIs: Results of a Disproportionality Analysis

  • Manfred Hauben
  • Lester Reich
Correspondence

Keywords

Glaucoma Fluvoxamine Escitalopram Angle Closure Glaucoma Spontaneous Reporting System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors are employees of Pfizer Inc, which manufactures and markets sertraline.

References

  1. 1.
    Costagliola C, Parmeggiani F, Sebastiani A. SSRIs and intraocular pressure modifications: evidence, therapeutic impli cations and possible mechanisms. CNS Drugs 2004; 18(8): 475–84PubMedCrossRefGoogle Scholar
  2. 2.
    Ahmad S. Fluoxetine and glaucoma [letter]. DICP 1991; 25: 436PubMedGoogle Scholar
  3. 3.
    Kirwan JF, Subak-Sharpe I, Teimory M. Bilateral acute angle closure glaucoma after administration of paroxetine [letter]. Br J Ophthalmol 1997; 81: 252PubMedCrossRefGoogle Scholar
  4. 4.
    Lewis CF, DeQuardo JR, DuBose C, et al. Acute angle-closure glaucoma and paroxetine. J Clin Psychiatry 1997; 58: 123–4PubMedCrossRefGoogle Scholar
  5. 5.
    Eke T, Bates AK. Acute angle closure glaucoma associated with paroxetine [letter]. BMJ 1997; 314: 1387PubMedCrossRefGoogle Scholar
  6. 6.
    Bennett HG, Wyllie AM. Paroxetine and acute angle-closure glaucoma. Eye 1999; 13: 691–2PubMedCrossRefGoogle Scholar
  7. 7.
    Browning AC, Reck AC, Chisholm IH, et al. Acute angle closure glaucoma presenting in a young patient after administration of paroxetine. Eye 2000; 14: 406–8PubMedCrossRefGoogle Scholar
  8. 8.
    Jimenez-Jimenez FJ, Orti-Pareja M, Zurdo JM. Aggravation of glaucoma with fluvoxamine. Ann Pharmacother 2001; 35: 1565–6PubMedCrossRefGoogle Scholar
  9. 9.
    Meyboom RH, Egberts AC, Edwards IR, et al. Principles of signal detection in pharmacovigilance. Drug Saf 1997; 16(6): 355–65PubMedCrossRefGoogle Scholar
  10. 10.
    Hauben M. A brief primer on automated signal detection. Ann Pharmacother 2002; 37(7/8): 1117–26Google Scholar
  11. 11.
    Finney DJ. The detection of adverse reactions to therapeutic drugs. Stat Med 1982; 1(2): 153–61PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  • Manfred Hauben
    • 1
    • 2
    • 3
  • Lester Reich
    • 1
  1. 1.Risk Management StrategyPfizer Inc.New YorkUSA
  2. 2.Department of MedicineNew York University School of MedicineNew YorkUSA
  3. 3.Departments of Pharmacology and Community and Preventive MedicineNew York Medical CollegeValhallaUSA

Personalised recommendations